Steven Cohen Forte Biosciences, Inc. Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.96 - $36.67 $1.98 Million - $24.5 Million	-668,449 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$31.5 - $42.5 $5.3 Million - $7.15 Million	168,249 Added 33.64%	668,449 $22.5 Million
Q1 2021 May 17, 2021	BUY	$25.01 - $40.24 $10.4 Million - $16.7 Million	415,200 Added 488.47%	500,200 $17.1 Million
Q4 2020 Feb 16, 2021	BUY	$28.66 - $46.79 $2.44 Million - $3.98 Million	85,000 New	85,000 $3.1 Million

19M

3.1K

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $117M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.